When providing wound care for a client with burns, which of the following actions is the most effective strategy to prevent infection?

Multiple sclerosis (MS) is a chronic autoimmune demyelinating disorder of the central nervous system characterized by periods of relapse and remission. Disease-modifying therapies are used to reduce inflammatory activity, decrease relapse frequency, and slow long-term neurological deterioration. Interferon beta is one of the first-line treatments for relapsing forms of MS. It works by modulating the immune response to reduce autoimmune attack on myelin.

Rationale:
A. Interferon beta medications are indicated for acute relapses of multiple sclerosis is incorrect because these drugs are not used to treat acute exacerbations. Acute relapses are typically managed with high-dose corticosteroids to rapidly reduce inflammation. Interferon beta is a long-term disease-modifying therapy rather than an acute treatment.

B. Interferon beta medication may help to reduce the frequency of relapses and slow disease progression in multiple sclerosis is correct. It modulates immune system activity, reducing inflammatory attacks on myelin and decreasing the number and severity of relapses. Over time, this can also slow the accumulation of neurological disability associated with MS progression.

C. Interferon beta medications are contraindicated for clients who have multiple sclerosis is incorrect because these drugs are specifically approved for use in relapsing forms of MS. They are commonly prescribed as part of first-line disease-modifying therapy to manage the long-term course of the disease.

D. Interferon beta medications are only effective in managing symptoms but do not alter the disease course of multiple sclerosis is incorrect because these medications are disease-modifying rather than purely symptomatic. They reduce disease activity by decreasing immune-mediated damage to myelin, thereby influencing the progression of MS rather than only relieving symptoms.

Nitroglycerin is a nitrate vasodilator commonly used for the rapid relief and prevention of angina pectoris. Sublingual tablets act quickly by relaxing vascular smooth muscle and improving myocardial oxygen supply while reducing cardiac workload. Because nitroglycerin is highly sensitive to light, heat, air, and moisture, improper storage can reduce its effectiveness. Correct storage is essential to maintain potency and ensure therapeutic action during an acute chest pain episode.

Rationale:
A. Storing nitroglycerin in an open bottle or pill organizer is inappropriate because exposure to air, moisture, and light causes the tablets to lose potency rapidly. The original tightly sealed glass container is specifically designed to protect the medication from environmental degradation. Using pill organizers increases the risk that the client will receive ineffective medication during an angina attack.

B. Nitroglycerin should be stored in a light-resistant container because the medication is highly unstable when exposed to light and air. The original dark-colored glass bottle helps preserve potency and prevents breakdown of the active ingredient. Keeping the lid tightly closed and avoiding transfer to other containers helps ensure the medication remains effective when urgently needed.

C. Refrigeration is not recommended for routine storage of sublingual nitroglycerin tablets. Extreme temperatures and moisture from refrigeration can negatively affect the medication and compromise tablet stability. The preferred storage method is at room temperature in the original light-resistant container, away from heat, humidity, and direct sunlight.

D. Nitroglycerin is not routinely discarded after one month regardless of appearance. Most recommendations advise replacing tablets approximately every 6 months after opening, depending on manufacturer guidance and storage conditions. The key concern is loss of potency rather than visible changes, so the medication should be checked based on expiration guidance rather than an arbitrary one-month rule.